These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26586283)

  • 21. Derivation of chicken induced pluripotent stem cells tolerant to Newcastle disease virus-induced lysis through multiple rounds of infection.
    Susta L; He Y; Hutcheson JM; Lu Y; West FD; Stice SL; Yu P; Abdo Z; Afonso CL
    Virol J; 2016 Dec; 13(1):205. PubMed ID: 27919263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a commercial Newcastle vaccine against velogenic viscerotropic Newcastle disease virus.
    Benson HN; Wenger DR; Beard PD
    Avian Dis; 1975; 19(3):566-72. PubMed ID: 1164321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a virosome vaccine for Newcastle disease virus.
    Kapczynski DR; Tumpey TM
    Avian Dis; 2003; 47(3):578-87. PubMed ID: 14562884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease.
    Ge J; Wang X; Tian M; Wen Z; Feng Q; Qi X; Gao H; Wang X; Bu Z
    Vaccine; 2014 Mar; 32(13):1514-21. PubMed ID: 24486349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Previous infection with virulent strains of Newcastle disease virus reduces highly pathogenic avian influenza virus replication, disease, and mortality in chickens.
    Costa-Hurtado M; Afonso CL; Miller PJ; Shepherd E; Cha RM; Smith D; Spackman E; Kapczynski DR; Suarez DL; Swayne DE; Pantin-Jackwood MJ
    Vet Res; 2015 Sep; 46(1):97. PubMed ID: 26394750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
    Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
    J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of baculovirus vector with WPRE regulatory element to express Newcastle disease virus F gene in primary chicken embryo cells].
    Gao D; Ping W; Jin L; Shen W; Song G; Tang X; An Q; Shen Y; Ge J
    Wei Sheng Wu Xue Bao; 2014 Apr; 54(4):455-62. PubMed ID: 25007659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental vaccination of SPF chickens against Newcastle disease using the method of coated-millet vaccine from a thermotolerant variant of the LaSota virus].
    Nguyen-Ba-Vy
    Rev Elev Med Vet Pays Trop; 1994; 47(4):357-60. PubMed ID: 7770658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. interactions between escherichia coli and Newcastle disease virus in chickens.
    El Tayeb AB; Hanson RP
    Avian Dis; 2002; 46(3):660-7. PubMed ID: 12243530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and evaluation of a recombinant Newcastle disease virus expressing the glycoprotein (G) of avian metapneumovirus subgroup C as a bivalent vaccine in turkeys.
    Hu H; Roth JP; Estevez CN; Zsak L; Liu B; Yu Q
    Vaccine; 2011 Nov; 29(47):8624-33. PubMed ID: 21925228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of minimum hemagglutinin units in an inactivated Newcastle disease virus vaccine for clinical protection of chickens from exotic Newcastle disease virus challenge.
    Liljebjelke KA; King DJ; Kapczynski DR
    Avian Dis; 2008 Jun; 52(2):260-8. PubMed ID: 18646455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken.
    Dilaveris D; Chen C; Kaiser P; Russell PH
    Vaccine; 2007 May; 25(19):3792-9. PubMed ID: 17321645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
    Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
    Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of chicken interleukin-2 by a highly virulent strain of Newcastle disease virus leads to decreased systemic viral load but does not significantly affect mortality in chickens.
    Susta L; Diel DG; Courtney S; Cardenas-Garcia S; Sundick RS; Miller PJ; Brown CC; Afonso CL
    Virol J; 2015 Aug; 12():122. PubMed ID: 26253150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.